Thermo Fisher Scientific Share-Based Compensation Expense decreased by 12.0% to $44.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.0%, from $50.00M to $44.00M.
pfe_share_based_compensation_expense| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.00M | $29.00M | $2.00M | $95.00M | $5.00M | $34.00M | $65.00M | $32.00M | $103.00M | $81.00M | $75.00M | $50.00M | $44.00M |
| QoQ Change | — | -66.7% | -93.1% | >999% | -94.7% | +580.0% | +91.2% | -50.8% | +221.9% | -21.4% | -7.4% | -33.3% | -12.0% |
| YoY Change | — | — | — | +9.2% | -82.8% | >999% | -31.6% | +540.0% | +202.9% | +24.6% | +134.4% | -51.5% | -12.0% |